
Peptides
Peptides are short chains of amino acids linked by peptide bonds, serving as important biological molecules that play key roles in cellular processes. They function as hormones, neurotransmitters, and signaling molecules, and are widely used in therapeutic and diagnostic applications. Peptides are also crucial in research for studying protein interactions, enzyme activities, and cell signaling pathways. At CymitQuimica, we provide a diverse selection of high-quality peptides to support your research and development needs in biotechnology and pharmaceuticals.
Subcategories of "Peptides"
Products of "Peptides"
Sort by
H-AAEGLDTQR-OH
Peptide H-AAEGLDTQR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AAEGLDTQR-OH include the following: Positron Emission Tomography Tracer Design of Targeted Synthetic Peptides via 18F-Sydnone Alkyne Cycloaddition MK Narayanam, BT Lai, JM Loredo - Bioconjugate , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.1c00379ANAPC10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ANAPC10 antibody, catalog no. 70R-5616Purity:Min. 95%PACAP-27 (human, mouse, ovine, porcine, rat)
CAS:PACAP 1-27 (Pituitary adenylate cyclase-activating polypeptide 27) is a potent stimulator of adenylyl cyclase and increases cAMP levels.Formula:C142H224N40O39SMolecular weight:3,147.65 g/molN-(9-Fluorenylmethoxycarbonyl)-L-norleucine
CAS:Formula:C21H23NO4Purity:97%Color and Shape:SolidMolecular weight:353.4116PTX3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PTX3 antibody, catalog no. 70R-5923Purity:Min. 95%H-IGHPAPNFK-OH
Peptide H-IGHPAPNFK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IGHPAPNFK-OH include the following: Use of Cytokines to Prevent Breast Cancer Growth and Progression PM Grimley - 1995 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA382941H-ASPAFLASQNTK-OH
Peptide H-ASPAFLASQNTK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ASPAFLASQNTK-OH include the following: Screening and identification of pregnancy zone protein and leucine-rich alpha-2-glycoprotein as potential serum biomarkers for early-onset myocardial infarction C Xuan , H Li, LL Li, QW Tian, Q Wang - Proteomics-Clinical , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201800079H-SLSLSLGK^-OH
Peptide H-SLSLSLGK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLSLSLGK^-OH include the following: chromatography mass spectrometry with a heavy peptide response curve accurately measures unprocessed C-terminal lysine during peptide mapping analysis of T Greer , ROB Johnson, M Cejkov, X Zheng - Journal of Pharmaceutical , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708521000753 An 18O-Labeling Assisted LC-MS Method for Accurate Quantitation of Unprocessed C-Terminal Lysine in Therapeutic Monoclonal Antibodies S Wang , AP Liu , N Li - Journal of the American Society for Mass , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jasms.0c00149 C-terminal modification of monoclonal antibody drugs: amidated species as a general product-related substance M Tsubaki, I Terashima, K Kamata, A Koga - International journal of , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0141813012003704 Visible Light Degradation of a Monoclonal Antibody in a High-Concentration Formulation: Characterization of a Tryptophan-Derived Chromophoric Photo-product by I Prajapati , NR Larson , S Choudhary - Molecular , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.1c00043 Pharmacokinetic characterization and tissue distribution of fusion protein therapeutics by orthogonal bioanalytical assays and minimal PBPK modeling H Sugimoto , S Chen, MG Qian - Molecules, 2020 - mdpi.comhttps://www.mdpi.com/1420-3049/25/3/535 Development of an LC-MS/MS method for absolute quantification of IgG4 by evaluating dependence on the digestion efficiency using a non-cleavable/dually D Sasaki, H Kashiwagura, Y Teruuchi - Biochemical and Biophysical , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X23011737 Interlaboratory evaluation of a user-friendly benchtop mass spectrometer for multiple-attribute monitoring studies of a monoclonal antibody CI Butre, V D'atri , H Diemer, O Colas, E Wagner - Molecules, 2023 - mdpi.comhttps://www.mdpi.com/1420-3049/28/6/2855 Observation of Heavy-Chain C-Terminal Des-GK Truncation in Recombinant and Human Endogenous IgG4 B Shah, YX Zhu , J Wypych, Z Zhang - Journal of Pharmaceutical Sciences, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354923001922 Observation of heavy-chain C-terminal amidation in human endogenous IgG B Shah, M Li, J Wypych, MK Joubert, Z Zhang - Journal of Pharmaceutical , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354922002568TMEM63B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM63B antibody, catalog no. 70R-7101Purity:Min. 95%DUXA Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DUXA antibody, catalog no. 70R-8697Purity:Min. 95%H-YMIGVLLGV-OH
Peptide H-YMIGVLLGV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YMIGVLLGV-OH include the following: Carcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trials M Turriziani, M Fantini , M Benvenuto - Recent patents on , 2012 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/pra/2012/00000007/00000003/art00004 Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements E Huarte , P Sarobe, J Lu, N Casares, JJ Lasarte - Clinical cancer , 2002 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/8/7/2336/2891584-Aminophthalic Acid
CAS:Formula:C8H7NO4Purity:>95.0%(T)Color and Shape:White to Gray to Brown powder to crystalMolecular weight:181.15SIVmac239 - 83
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:1,553.9 g/molAbz-Ala-Phe-Arg-Phe-Ser-Gln-EDDnp
CAS:Abz-Ala-Phe-Arg-Phe-Ser-Gln-EDDnp is a peptide that belongs to the group of picolinic acid. It has been shown to cause neuronal death and synergistic cell lysis in vitro. Abz-Ala-Phe-Arg-Phe-Ser-Gln-EDDnp inhibits the mitochondrial membrane potential, which leads to cytochrome c release, caspase activation, and subsequent apoptosis. Abz also inhibits basic protein synthesis and causes proteolytic degradation of cellular proteins.Formula:C50H63N15O13Purity:Min. 95%Molecular weight:1,082.15 g/molLCBiot-CDDYYYGFGCNKFCRPR-OH
Peptide LCBiot-CDDYYYGFGCNKFCRPR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-CDDYYYGFGCNKFCRPR-OH include the following: Antifibrotic therapies to control cardiac fibrosis Z Fan , J Guan - Biomaterials research, 2016 - spj.science.orghttps://spj.science.org/doi/abs/10.1186/s40824-016-0060-8 GANT61 exerts anticancer cell and anticancer stem cell capacity in colorectal cancer by blocking the Wnt/beta"âcatenin and Notch signalling pathways Y Si, L Li, W Zhang, Q Liu, B Liu - Oncology Reports, 2022 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/or.2022.8397 Biomaterial-mediated presentation of jagged-1 mimetic ligand enhances cellular activation of notch signaling and bone regeneration Y Deng, R Li , H Wang , B Yang, P Shi , Y Zhang - ACS , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsnano.1c08728 Fetal dermal mesenchymal stem cell-derived exosomes accelerate cutaneous wound healing by activating notch signaling X Wang, Y Jiao, Y Pan, L Zhang, H Gong - Stem Cells , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2019/2402916 Mitigation of pathological parameters under Jagged1 influence in DMD knockout zebrafish and patient-derived myoblast cultures V Nesari, J Vaishnav , S Sharma, U Nongthomba - 2023 - nopr.niscpr.res.inhttps://nopr.niscpr.res.in/handle/123456789/62534 Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis S Mittal, D Subramanyam, D Dey , RV Kumar - Molecular cancer, 2009 - Springerhttps://link.springer.com/article/10.1186/1476-4598-8-128 Tbx1 regulates brain vascularization S Cioffi, S Martucciello, FG Fulcoli - Human Molecular , 2014 - academic.oup.comhttps://academic.oup.com/hmg/article-abstract/23/1/78/722596 Notch Signaling Slows Down the Progression of Embryonic Myogenic Differentiation in Landrace S Cai, Q Zhu, B Hu, X Luo, R Yuan, F Liang, T Duo - 2020 - researchsquare.comhttps://www.researchsquare.com/article/rs-104072/latest Notch signaling leads to a slower progression of embryonic myogenic differentiation in Landrace than in Langtang pigs: Notch signaling prevents embryonic S Cai, B Hu, Q Zhu, T Duo, X Wang - Acta Biochimica et , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827795/ LSD1 represses a neonatal/reparative gene program in adult intestinal epithelium RT Zwiggelaar, HT Lindholm , M Fosslie - Science , 2020 - science.orghttps://www.science.org/doi/abs/10.1126/sciadv.abc0367 Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis RCA Sainson , J Aoto , MN Nakatsu - The FASEB , 2005 - Wiley Online Libraryhttps://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.04-3172fje Self-assembling peptides as an emerging platform for the treatment of metabolic syndrome LA Castillo-DacaÂaz, JA Ruiz-Pacheco - International Journal , 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.2147/IJN.S278189 Antifibrotic therapies to control cardiac fibrosis. pdf J Guan - 2019 - hra.figshare.comhttps://hra.figshare.com/articles/journal_contribution/Antifibrotic_therapies_to_control_cardiac_fibrosis_pdf/7800977/files/14519153.pdf Notch1 cardioprotection in myocardial ischemia/reperfusion involves reduction of oxidative/nitrative stress H Pei, Q Yu, Q Xue, Y Guo, L Sun, Z Hong - Basic Research in , 2013 - Springerhttps://link.springer.com/article/10.1007/s00395-013-0373-x Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells G Ferrari-Toninelli, SA Bonini, D Uberti - Neuro , 2010 - academic.oup.comhttps://academic.oup.com/neuro-oncology/article-abstract/12/12/1231/1130248 Rational design of gold nanocarrier for the delivery of JAG-1 peptide CT Matea , T Mocan , F Tabaran , C Iancu - Journal of , 2015 - Springerhttps://link.springer.com/article/10.1186/s12951-015-0100-x Ex vivo culture of adult CD34+ stem cells using functional highly porous polymer scaffolds to establish biomimicry of the bone marrow niche CE Severn , AM Eissa , CR Langford , A Parker - Biomaterials, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961219306325D-Asparagine, N2-[(phenylmethoxy)carbonyl]-
CAS:Formula:C12H14N2O5Purity:97%Color and Shape:SolidMolecular weight:266.25Z-Ala-Ala-Asp-CMK
CAS:Z-Ala-Ala-Asp-chloromethylketone (Z-AAD-CMK) is a selective inhibitor of granzyme B [1].Formula:C19H24ClN3O7Purity:98%Color and Shape:SolidMolecular weight:441.86N-Acetyl-D-penicillamine
CAS:Formula:C7H13NO3SPurity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:191.25Amino-dPEG®4-t-Butyl Ester
CAS:Amino-dPEG®4-t-Butyl Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Amino-dPEG®4-t-Butyl Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Formula:C22H42O13Purity:Min. 95%Molecular weight:514.56 g/molACVR1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACVR1 antibody, catalog no. 70R-7319Purity:Min. 95%